Read our new case study to discover how market research helped a client understand how to bring a new cancer treatment into the market
This case study is focused on Cutaneous T Cell Lymphoma (CTCL), a rare type of cancer that begins in white blood cells called T cells (T lymphocytes) and affects the body’s immune system and the skin.
The study was conducted with a clinical-stage biotechnology company that focuses on the development of therapeutic antibodies for improvement in cancer treatment. The aim was to understand the data that clinical trials need to demonstrate in order to bring the treatment into the market. The research was carried out across the USA and five key European Markets.
Research into rare diseases such as CTCL can prove challenging. Below you can learn how our global team of experts helped design, recruit and interview M3 Global Research panellists to deliver a successful result.
The study was conducted with a clinical-stage biotechnology company that focuses on the development of therapeutic antibodies for improvement in cancer treatment. The aim was to understand the data that clinical trials need to demonstrate in order to bring the treatment into the market. The research was carried out across the USA and five key European Markets.
Research into rare diseases such as CTCL can prove challenging. Below you can learn how our global team of experts helped design, recruit and interview M3 Global Research panellists to deliver a successful result.
Not a Member of our Panel Yet?
Are you working as a health care professional? Are you looking for different ways to earn an extra income as a healthcare professional? If so, we want to hear about your experiences and opinions.
Not a member of our panel yet?
Are you working as a health care professional? Are you looking for different ways to earn an extra income as a healthcare professional? If so, we want to hear about your experiences and opinions.
Recommended related articles:
The latest market research case study we conducted is about rare disease treatments in oncology with the aim to improve patient outcomes. Read more.
Market research case study on rare disease treatments in oncology
In this case study, one of the biggest healthcare organizations, the UK’s National Health Service (NHS) worked with the M3 panel to run a series of co-creation workshops. . Read more.
How market research has helped NHS patient engagement
1 comment
The power of research cannot be over emphasis.